ALERT ALERT: A Public Session Special Committee meeting of the New Jersey State Board of Medical Examiners is scheduled virtually for June 27, 2024. The meeting is scheduled to be called to Order at 1:00 P.M. Formal action may be taken at the meeting. A copy of the Agenda can be accessed at
View agemda For the public to participate in the meeting, from your computer, tablet or smartphone – Topic: Special Committee Meeting - Hearing
Time: Jun 27, 2024 01:00 PM Eastern Time (US and Canada)
Join ZoomGov Meeting Meeting ID: 161 133 0010
Passcode: 654266 One tap mobile
+16692545252,,1611330010#,,,,*654266# US (San Jose)
+16468287666,,1611330010#,,,,*654266# US (New York) Dial by your location
• +1 669 254 5252 US (San Jose)
• +1 646 828 7666 US (New York)
• +1 646 964 1167 US (US Spanish Line)
• +1 669 216 1590 US (San Jose)
• +1 415 449 4000 US (US Spanish Line)
• +1 551 285 1373 US (New Jersey)
• 833 435 1820 US Toll-free
• 833 568 8864 US Toll-free Meeting ID: 161 133 0010
Passcode: 654266 Find your local number: https://njoag.zoomgov.com/u/aeeLUI0wgA |
ALERT The Office of the Attorney General (OAG), Division of Consumer Affairs (CA), on behalf of the State Board of Medical Examiners (BME), is seeking bid proposals for a medical consultant. The purpose of this Bid Solicitation is to solicit proposals from one (1) qualified medical consultant to provide medical expertise and knowledge to the BME. Click here for additional information |
|
ALERT The Division of Consumer Affairs issued an alert to support health care practitioners in their efforts to protect patient data and information from disclosure. This alert, available
here, identifies steps that practitioners can take to avoid collecting unnecessary data and to safeguard the data that they do collect and store. |
ATTENTION The U.S. Department of Health and Human Services (HHS) recently announced Practice Guidelines which authorized physicians to utilize an exemption from certain certification requirements under the Controlled Substances Act to prescribe buprenorphine for the treatment of opioid use disorder. The
Practice Guidelines were sent to the Office of the Federal Register (OFR) on January 12, 2021, but were not yet published. It has been reported that the Biden Administration has delayed the implementation of the Practice Guidelines setting forth that exemption, as a
regulatory freeze has been implemented with respect to rules that have been sent to the OFR but not published, requiring that they be withdrawn for review [and approval]. This means that physicians who wish to prescribe buprenorphine for opioid use disorder must continue to adhere to the full DATA 2000 waiver requirements. HHS is expected to announce this reversal.
|
New Jersey's Board of Medical Examiners is responsible for protecting the public's health and safety by determining qualifications of applicants for licensure, establishing standards for practice, and disciplining licensees who do not adhere to those requirements. In addition to physicians and podiatrists, the Board licenses and certifies certain other health care professionals.
On this site you will find important information for consumers, licensees, applicants, hospitals, managed care entities and other institutions. You can learn more about the Medical Board and its activities, read summaries of Board actions, search for licensees by name or profession, get answers to frequently asked questions and more.
- Consumers can search for a physician or learn more about their current doctor by clicking onto the New Jersey Health Care Profile link. They may file a complaint, if necessary, about a physician or podiatrist or contact a member of the Medical Board's staff to check on the status of a complaint filed previously.
- Doctors and those in the process of becoming doctors can access online applications and renewal forms and learn more about our programs, their responsibilities, and the related activities of other agencies and organizations.
- Hospitals, managed care entities and other institutions can find access to verification services.
To keep the public informed of the Board's activities, this site will be updated regularly and will post agendas, minutes, rule proposals, and licensee status.
Our goal is to ensure that the public and our licensees have access to services and information vital to the continued delivery of health care in New Jersey. We encourage you to use the site often, and we welcome your feedback.
